Showing results (1161-1170 of 2,951) with videos related to
Sort By:
Pageof 296
Cancer Investigation|October 24, 2013
Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitroShilong Fu, Lihua Dong, Wei Sun, et al.Cancer Investigation|October 16, 2013
Loss of LDOC1 expression by promoter methylation in cervical cancer cellsMarie-Luise Buchholtz, Julia Jückstock, Elena Weber, et al.Cancer Investigation|October 16, 2013
Polymorphic AAAG repeat length in estrogen-related receptor gamma (ERRγ) and risk of breast cancer in Iranian womenPadideh Karimi, Simin Hematti, Foruzan Safari, et al.Cancer Investigation|October 3, 2013
Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculatureBrent D Van Rite, John J Krais, Mohamad Cherry, et al.Cancer Investigation|October 3, 2013
Frontline therapy for multiple myeloma: a concise review of the evidence based on randomized clinical trialsSobia Yaqub, Gabriela Ballester, Oscar BallesterCancer Investigation|April 26, 2012
Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalitiesHiroshi Shigetomi, Taihei Tsunemi, Shoji Haruta, et al.Cancer Investigation|January 1, 1997
A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapyB S Kasimis, E Tapazoglou, P Schulman, et al.Cancer Investigation|January 1, 1997
A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancerR Dreicer, J D Kemp, L D Stegink, et al.Cancer Investigation|March 10, 2010
Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?Nichola Cruickshanks, Leroy Shervington, Rahima Patel, et al.Cancer Investigation|March 10, 2010
Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesisYufeng Xie, Weihua Sheng, Jim Xiang, et al.Pageof 296